Nuclear factor erythroid 2–related factor 2 (NRF2) is a pivotal transcription factor that regulates redox signaling, playing a protective role in inflammation. Citraconate is verified as the strongest NRF2 agonist among its isomers. Dimethyl citraconate (DMC), an esterified derivative of citraconate, holds the potential for activating NRF2 and relieving inflammation. Here, we show that DMC is a strong NRF2-activating compound, stabilizing the intracellular NRF2 level and its nuclear translocation. DMC increases the expression levels of NRF2 downstream genes, thereby restricting the accumulation of reactive oxygen species and performing anti-inflammatory functions. The local administration of DMC effectively alleviates periodontal destruction in a ligation-induced periodontitis mouse model, elevating the NRF2 levels and downstream antioxidant enzymes. Moreover, the protective effect of DMC against periodontitis is absent in Nfe2l2-/- mice. Mechanically, DMC prolongs the half-life of NRF2 and facilitates its dissociation from KEAP1 (Kelch-like ECH-associated protein 1), which suggests that DMC interrupts the crosstalk between KEAP1 and NRF2. Collectively, our findings illustrate the role of DMC in activating NRF2 and ameliorating periodontal inflammation, suggesting its therapeutic potential for inflammation-related diseases.
AdinolfiSPatinenTJawahar DeenAPitkänenSHärkönenJKansanenEKüblbeckJLevonenA-L.2023. The KEAP1-NRF2 pathway: targets for therapy and role in cancer. Redox Biol. 63:102726. doi:10.1016/j.redox.2023.102726
2.
BambouskovaMGorvelLLampropoulouVSergushichevALoginichevaEJohnsonKKorenfeldDMathyerMEKimHHuangL-H, et al. 2018. Electrophilic properties of itaconate and derivatives regulate the IκBζ–ATF3 inflammatory axis. Nature. 556(7702):501–504.
3.
ChappleILCMatthewsJB.2007. The role of reactive oxygen and antioxidant species in periodontal tissue destruction. Periodontol2000. 43:160–232.
4.
ChenFElgaherWAMWinterhoffMBüssowKWaqasFHGranerEPires-AfonsoYCasares PerezLde la VegaLSahiniN, et al. 2022. Citraconate inhibits ACOD1 (IRG1) catalysis, reduces interferon responses and oxidative stress, and modulates inflammation and cell metabolism. Nat Metab. 4(5):534–546.
5.
ChiuAVSaighMAMcCullochCAGlogauerM.2017. The role of NrF2 in the regulation of periodontal health and disease. J Dent Res. 96(9):975–983.
6.
CuadradoAMandaGHassanAAlcarazMJBarbasCDaiberAGhezziPLeónRLópezMGOlivaB, et al. 2018. Transcription factor NRF2 as a therapeutic target for chronic diseases: a systems medicine approach. Pharmacol Rev. 70(2):348–383.
7.
CuadradoARojoAIWellsGHayesJDCousinSPRumseyWLAttucksOCFranklinSLevonenA-LKenslerTW, et al. 2019. Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases. Nat Rev Drug Discov. 18(4):295–317.
8.
D’AiutoFNibaliLParkarMPatelKSuvanJDonosN.2010. Oxidative stress, systemic inflammation, and severe periodontitis. J Dent Res. 89(11):1241–1246.
9.
DarveauRP. 2010. Periodontitis: a polymicrobial disruption of host homeostasis. Nat Rev Microbiol. 8(7):481–490.
10.
de la VegaMRChapmanEZhangDD. 2018. NRF2 and the hallmarks of cancer. Cancer Cell. 34(1):21–43.
11.
Dinkova-KostovaATCoppleIM. 2023. Advances and challenges in therapeutic targeting of NRF2. Trends Pharmacol Sci. 44(3):137–149.
12.
ElAzzounyMTomCTMBEvansCROlsonLLTangaMJGallagherKAMartinBRBurantCF. 2017. Dimethyl itaconate is not metabolized into itaconate intracellularly. J Biol Chem. 292(12):4766–4769.
13.
GencoRJSanzM.2020. Clinical and public health implications of periodontal and systemic diseases: an overview. Periodontol 2000. 83(1):7–13.
14.
HajishengallisG. 2014. Immunomicrobial pathogenesis of periodontitis: keystones, pathobionts, and host response. Trends Immunol. 35(1):3–11.
15.
HajishengallisGChavakisT.2021. Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities. Nat Rev Immunol. 21(7):426–440.
16.
HaoJYangTZhouYGaoG-YXingFPengYTaoY-YLiuC-H.2017. Serum metabolomics analysis reveals a distinct metabolic profile of patients with primary biliary cholangitis. Sci Rep. 7(1):784. doi:10.1038/s41598-017-00944-9
17.
HosonoYUchidaSShinkaiMTownsendCEKellyCNNaylorMRLeeH-WKanamitsuKIshiiMUekiR, et al. 2023. Amide-to-ester substitution as a stable alternative to N-methylation for increasing membrane permeability in cyclic peptides. Nat Commun. 14(1):1416. doi:10.1038/s41467-023-36978-z
18.
LiYLiuLLiYSongWShaoBLiHLinWLiQShuaiXBaiM, et al. 2023. Alpha-ketoglutarate promotes alveolar bone regeneration by modulating M2 macrophage polarization. Bone Rep. 18:101671. doi:10.1016/j.bonr.2023.101671
19.
LiuLWangFSongWZhangDLinWYinQWangQLiHYuanQZhangS.2024. Magnesium promotes vascularization and osseointegration in diabetic states. Int J Oral Sci. 16(1):10. doi:10.1038/s41368-023-00271-y
20.
LiuR-XGuR-HLiZ-PHaoZ-QHuQ-XLiZ-YWangX-GTangWWangX-HZengY-K, et al. 2023. Trim21 depletion alleviates bone loss in osteoporosis via activation of YAP1/β-catenin signaling. Bone Res. 11(1):56. doi:10.1038/s41413-023-00296-3
21.
LiuSPiJZhangQ.2022. Signal amplification in the KEAP1-NRF2-ARE antioxidant response pathway. Redox Biol. 54:102389. doi:10.1016/j.redox.2022.102389
22.
MaQHeX.2012. Molecular basis of electrophilic and oxidative defense: promises and perils of Nrf2. Pharmacol Rev. 64(4):1055–1081.
23.
MuriJKopfM.2021. Redox regulation of immunometabolism. Nat Rev Immunol. 21(6):363–381.
24.
Musalem-DominguezOMontiel-CompanyJMAusina-MárquezVMorales-TatayJMAlmerich-SillaJM. 2023. Salivary metabolomic profile associated with cariogenic risk in children. J Dent. 136:104645. doi:10.1016/j.jdent.2023.104645
25.
PaiboonrungruangCXiongZLamsonDLiYBowmanBChemboJHuangCLiJLivingstonEWFrankJE, et al. 2023. Small molecule screen identifies pyrimethamine as an inhibitor of NRF2-driven esophageal hyperplasia. Redox Biol. 67:102901. doi:10.1016/j.redox.2023.102901
26.
ParkMDSilvinAGinhouxFMeradM.2022. Macrophages in health and disease. Cell. 185(23):4259–4279.
27.
SczepanikFSCGrossiMLCasatiMGoldbergMGlogauerMFineNTenenbaumHC. 2020. Periodontitis is an inflammatory disease of oxidative stress: we should treat it that way. Periodontol 2000. 84(1):45–68.
28.
ShiJZhangYZhangXChenRWeiJHouJWangBLaiHHuangY.2021. Remodeling immune microenvironment in periodontitis using resveratrol liposomes as an antibiotic-free therapeutic strategy. J Nanobiotechnology. 19(1):429. doi:10.1186/s12951-021-01175-x
29.
SiesHJonesDP. 2020. Reactive oxygen species (ROS) as pleiotropic physiological signalling agents. Nat Rev Mol Cell Biol. 21(7):363–383.
30.
SwainABambouskovaMKimHAndheyPSDuncanDAuclairKChubukovVSimonsDMRoddyTPStewartKM, et al. 2020. Comparative evaluation of itaconate and its derivatives reveals divergent inflammasome and type I interferon regulation in macrophages. Nat Metab. 2(7):594–602.
31.
WangHZhangHYaoLCuiLZhangLGaoBLiuWWuDChenMLiX, et al. 2018. Serum metabolic profiling of type 2 diabetes mellitus in Chinese adults using an untargeted GC/TOFMS. Clin Chim Acta. 477:39–47.
32.
WangYDengPLiuYWuYChenYGuoYZhangSZhengXZhouLLiuW, et al. 2020. Alpha-ketoglutarate ameliorates age-related osteoporosis via regulating histone methylations. Nat Commun. 11(1):5596. doi:10.1038/s41467-020-19360-1
33.
WeiYDengYMaSRanMJiaYMengJHanFGouJYinTHeH, et al. 2021. Local drug delivery systems as therapeutic strategies against periodontitis: a systematic review. J Control Release. 333:269–282.
34.
WinterhoffMChenFSahiniNEbensenTKuhnMKaeverVBähreHPesslerF.2021. Establishment, validation, and initial application of a sensitive LC-MS/MS assay for quantification of the naturally occurring isomers itaconate, mesaconate, and citraconate. Metabolites. 11(5):270. doi:10.3390/metabo11050270
35.
XinLZhouFZhangCZhongWXuSJingXWangDWangSChenTSongJ.2022. Four-octyl itaconate ameliorates periodontal destruction via Nrf2-dependent antioxidant system. Int J Oral Sci. 14(1):27. doi:10.1038/s41368-022-00177-1
36.
YamamotoMKenslerTWMotohashiH.2018. The KEAP1-NRF2 system: a thiol-based sensor-effector apparatus for maintaining redox homeostasis. Physiol Rev. 98(3):1169–1203.
37.
ZasłonaZO’NeillLAJ. 2020. Cytokine-like roles for metabolites in immunity. Mol Cell. 78(5):814–823.
38.
ZhaoWJiLLiJLiuDYanCZhangCWangXLiuYZhengS.2024. Mesaconate from Bacillus subtilisR0179 supernatant attenuates periodontitis by inhibiting Porphyromonas gingivalis in mice. J Periodontal Res [epub ahead of print 19 Nov 2024] in press. doi:10.1111/jre.13363
39.
ZhuJDjukovicDDengLGuHHimmatiFAbu ZaidMChioreanEGRafteryD.2015. Targeted serum metabolite profiling and sequential metabolite ratio analysis for colorectal cancer progression monitoring. Anal Bioanal Chem. 407(26):7857–7863.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
